<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03622060</url>
  </required_header>
  <id_info>
    <org_study_id>HerminaHCK</org_study_id>
    <nct_id>NCT03622060</nct_id>
  </id_info>
  <brief_title>Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion</brief_title>
  <acronym>NONERAO</acronym>
  <official_title>A Randomized Comparison of Post-procedural/Pre-hemostasis Intraarterial Nitroglycerin Versus Nicardipine to Reduce Radial Artery Occlusion After Transradial Catheterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hermina Heart Center Kemayoran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hermina Hospital Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hermina Heart Center Kemayoran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A total of 600 patients undergoing coronary procedures via transradial access using 6F sheath
      were randomized at the end of the procedure to receive either 250-µg nicardipine or 500-µg
      nitroglycerin administered to the radial artery through the radial sheath before sheath
      removal. A continuous patent hemostasis was applied in each patient with the use of an
      oximetry to maintain an oxygen saturation of &gt;95%, measured in the finger of the accessed arm
      until compression device was totally removed. The primary outcome is early RAO which was
      evaluated by color duplex ultrasonography of the accessed arteries at the day after the
      radial procedure. Secondary outcome was the change of blood pressure at 2-3 minutes after
      drug administration. Radial artery angiogram was performed after radial sheath insertion and
      doppler ultrasound of the accesed radial artery was examined at the day after the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Doppler ultrasound of the accessed artery was performed at the day after the radial procedure
      in all patients. The absence or presence of antegrade flow in the radial artery will be
      examined while compressing the ulnar artery as previously described.

      The internal lumen radial artery diameter was evaluated by doppler ultrasound as the distance
      between the inner walls of the artery by personnel that are blinded to the study protocol.

      Radial artery angiogram was performed soon after radial sheath insertion and the radial
      artery diameter was measured in AP projection in all patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2018</start_date>
  <completion_date type="Actual">May 22, 2019</completion_date>
  <primary_completion_date type="Actual">May 21, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>nitroglycerin and nicardipine</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The absence of antegrade radial artery flow by doppler evaluation</measure>
    <time_frame>24 hour</time_frame>
    <description>The absence of radial artery flow by doppler evaluation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure change</measure>
    <time_frame>2 minutes after drugs administration</time_frame>
    <description>Blood pressure change after drugs administration</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Radial Artery Injury at Wrist and Hand Level</condition>
  <condition>Occlusion of Artery</condition>
  <condition>Vasodilation</condition>
  <arm_group>
    <arm_group_label>Nitroglycerin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500 microgram intraarterial Nitroglycerin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicardipine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>200 microgram intraraterial Nicardipine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin</intervention_name>
    <description>200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal</description>
    <arm_group_label>Nicardipine</arm_group_label>
    <arm_group_label>Nitroglycerin</arm_group_label>
    <other_name>Nicardipine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing transradial catheterization

        Exclusion Criteria:

          -  Systolic blood pressure &lt; 100 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Surya Dharma, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hermina Hospital Kemayoran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hermina Heart Center</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10630</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <results_reference>
    <citation>Dharma S, Kedev S, Patel T, Kiemeneij F, Gilchrist IC. A novel approach to reduce radial artery occlusion after transradial catheterization: postprocedural/prehemostasis intra-arterial nitroglycerin. Catheter Cardiovasc Interv. 2015 Apr;85(5):818-25. doi: 10.1002/ccd.25661. Epub 2014 Sep 13. Erratum in: Catheter Cardiovasc Interv. 2019 Feb 15;93(3):565.</citation>
    <PMID>25179153</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 1, 2018</study_first_submitted>
  <study_first_submitted_qc>August 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>June 1, 2019</last_update_submitted>
  <last_update_submitted_qc>June 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hermina Heart Center Kemayoran</investigator_affiliation>
    <investigator_full_name>Surya Dharma, MD, PhD</investigator_full_name>
    <investigator_title>NONERAO study</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicardipine</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

